Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D. Brown, Terri S. Armstrong, Joseph Bovi et al.|Journal of Clinical Oncology|2020Cited by 827
How Does the Number of Brain Metastases Correlate With Normal Brain Exposure in Single-Isocenter Multitarget Multifraction Stereotactic RadiosurgeryDandan Zheng, Michael T. Milano, Jihyung Yoon et al.|Advances in Radiation Oncology|2024Cited by 3
A comprehensive evaluation of advanced dose calculation algorithms for brain stereotactic radiosurgeryJihyung Yoon, Dandan Zheng, Hyunuk Jung et al.|Journal of Applied Clinical Medical Physics|2023Cited by 2